Cladribine regimen for treating multiple sclerosis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7076 (2006.01) A61K 38/21 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2588966

The present invention is related to the use of Cladribine for the preparation of a pharmaceutical formulation for the treatment of multiple sclerosis, especially relapsing-remitting multiple sclerosis or early secondary progressive multiple sclerosis, wherein the preparation is to be the orally administered and wherein re-treatments are possible.

La présente invention se rapporte à l'utilisation de la cladribine pour produire une préparation pharmaceutique destinée à traiter la sclérose en plaques, en particulier la sclérose en plaques à périodes progressives et rémittentes, ladite préparation étant conçue pour être administrée par voie orale et pouvant être utilisée dans le cadre de traitements postérieurs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cladribine regimen for treating multiple sclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cladribine regimen for treating multiple sclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cladribine regimen for treating multiple sclerosis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1787630

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.